NCT02199873View on ClinicalTrials.gov

Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

September 30, 1998

Conditions
Healthy
Interventions
DRUG

BIIX 1 XX - single rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02199873 - Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers | Biotech Hunter | Biotech Hunter